The Title of the Video Would Go Here

Press Releases

2013 ::  2012 ::  2011 :: 2010 :: 2009 :: 2008 :: 2007 :: 2006 :: 2005 :: 2004

Michelle Nichols, in front with cap, is surrounded by her supportive family as she walks in the American Heart Association’s Richmond Heart Walk: (clockwise from left) cousin Kristal Ellworth, dad Jon Kettl, nephew William Bueche, husband Mike and stepsister Elizabeth Kettl. Michelle, whose SynCardia Total Artificial Heart implant bridged her to a donor heart transplant, volunteers with heart patients. She advocates for good health and organ donation.Women Can Help Save Their Own Lives
by Knowing the Symptoms of Heart Failure

Doctors told Michelle Nichols she had bronchitis. Instead, she was suffering from end-stage biventricular (both sides) heart failure. Once implanted with the SynCardia temporary Total Artificial Heart as a bridge to transplant, the symptoms and source of her heart failure were eliminated, allowing her body to get stronger for a donor heart transplant.

SynCardia Systems, Inc. has shown significant and steady growth in the number of Total Artificial Implants and SynCardia Certified Centers since 2010. On Nov. 26, the 150th SynCardia Heart was implanted in 2013 for another record-breaking year.SynCardia Hits Record-Setting 150th Implant
of the Total Artificial Heart in 2013

SynCardia Systems, Inc. continues to set records with the implantation of the year’s 150th SynCardia temporary Total Artificial Heart on Nov. 26, 2013. With almost three weeks left in 2013, SynCardia projects beating the 2012 record of 125 implants by 35 additional Total Artificial Hearts, the most patients ever implanted in one year.

“The record we are setting in 2013 for SynCardia Total Artificial Heart implants nearly doubles what was then our 2011 record-breaking year of 81 implants,” says SynCardia CEO and President Michael P. Garippa.

Smithsonian’s 'Bionic Man' Documentary Featuring the SynCardia Total Artificial Heart 
Earns British Film AwardSmithsonian’s “Bionic Man” Documentary Featuring
the SynCardia Total Artificial Heart Earns British Film Award

The story of the bionic man with the SynCardia temporary Total Artificial Heart has become an award-winning documentary that is making the rounds on television worldwide.

The television debut of “How to Build a Bionic Man” won a British Documentary Award for Best Science or Natural History Documentary. The award was presented Nov. 4, 2013 by The Grierson Trust, which annually honors the best documentary filmmaking in Britain and elsewhere. Judges described the documentary as a “mix of fascinating science and humor.” The project to put together a robot using the latest technology was a joint effort that included the Smithsonian and London’s Science Museum. The robot is on display at the Smithsonian Air & Space Museum until Dec. 11.

SynCardia Total Artificial Heart Makes Maryland Man Strong for His Ailing WifeSynCardia Total Artificial Heart Makes Maryland Man Strong
for His Ailing Wife

Without the SynCardia temporary Total Artificial Heart, a Maryland engineer who suffered from end-stage biventricular (both sides) heart failure feels he would not have been able to care for his wife during her own medical crisis nearly two years later.

1,200th Worldwide Implant of the SynCardia Total Artificial Heart Occurs in Indiana1,200th Worldwide Implant of the SynCardia Total Artificial Heart
Occurs in Indiana

An Indiana man has become the 1,200th person in the world to be implanted with the SynCardia temporary Total Artificial Heart. Patrick O’Hara is the first person in Indiana to receive the life-saving device and the first Hoosier to be discharged from the hospital with the Freedom® portable driver.

Dr. Francisco ArabiaBridge to Transplant Patients Should Not Suffer
from End-stage Biventricular Failure

November 5, 2013 – Veteran heart surgeon Dr. Francisco Arabia tells colleagues there is no reason for bridge to transplant patients to suffer from end-stage biventricular failure if they are bridged with the SynCardia temporary Total Artificial Heart because it is the only device that eliminates the source and symptoms of this severe form of heart disease.

Turkey Businessman, Two Years without a Human Heart, Goes Four-WheelingTurkey Businessman, Two Years without a Human Heart,
Goes Four-Wheeling

Omer Bayrak, who made headlines when he became the first patient in Turkey to be discharged from the hospital with his SynCardia temporary Total Artificial Heart powered by the Freedom portable driver, continues to live at home with his family to wait for a matching donor heart. Mr. Bayrak has returned to work and, as time allows, recreation.

Smithsonian’s 'Bionic Man' TV Special and Exhibit Feature the SynCardia Total Artificial HeartSmithsonian’s “Bionic Man” TV Special and Exhibit
Feature the SynCardia Total Artificial Heart

A human-like bionic man envisioned in popular culture may be years away, but there’s one manmade organ that already is saving lives: the SynCardia temporary Total Artificial Heart.

Scientists and roboticists researched and used the most advanced technology they could find to build the 2013 version of the bionic man, complete with prosthetic body parts and manmade organs. The documentary and complimentary museum exhibits are part of a collaborative effort that includes the Smithsonian Museum, London’s Science Museum, the Smithsonian Cable Channel and England’s Channel 4.

Knowing your Family’s Heart Disease History Could Help Save Your LifeKnowing your Family’s Heart Disease History Could Help Save Your Life

Kevin Stroh, 25, was fighting for his life against congestive heart failure, the same disease that claimed the life of his 29-year-old father. Thanks to the world’s first and only FDA-approved SynCardia temporary Total Artificial Heart, this Southern California resident had a much different outcome.

Case Report on 14-Year-Old Pediatric Patient Bridged to Transplant with SynCardia Total Artificial Heart Published in the Journal Perfusion
Case Report on 14-Year-Old Pediatric Patient Bridged to Transplant with SynCardia Total Artificial Heart Published in the Journal Perfusion

Surgeons in Phoenix, Arizona, successfully implanted the SynCardia temporary Total Artificial Heart into a 14-year-old boy with biventricular (both sides) heart failure and diffuse clot formation in the left ventricle using diagnostic technology to ensure its proper fit prior to actual surgery. The patient was supported and rehabilitated for 11 days and subsequently transplanted.

As of September 24, 2013 the SynCardia Total Artificial Heart has been implanted 125 times, equaling the 125 SynCardia hearts implanted in all of 2012. The Freedom® portable driver is the world's first wearable power supply for the SynCardia Total Artificial Heart.Surgeons Worldwide Implanted a Record
125 SynCardia Total Artificial Hearts So Far in 2013

On Sept. 24, 2013, the 125th implant of the SynCardia temporary Total Artificial Heart was performed. This number equals all implants performed worldwide in 2012 and a 244% increase over 2011. SynCardia Systems, Inc. projects concluding 2013 with another new record – 180 Total Artificial Heart implants in one year, the company announced today.

Matthew Green (pictured with his wife Gill and son Dylan) became the first patient in the United Kingdom to be discharged from the hospital with the SynCardia Total Artificial Heart, powered by the Freedom® portable driver, on Aug. 2, 2011. Mr. Green was supported for over 600 days before receiving his donor heart earlier this year.UK Man Without Human Heart Leaves Papworth Hospital
with New Donor Heart

SynCardia Systems, Inc. announced today that Matthew Green, the UK’s 1st patient to be discharged with the SynCardia temporary Total Artificial Heart has been successfully bridged to transplant after almost two years of support.

A dying heart doesn’t pump enough blood to sustain the body, causing vital organs to shut down, which can lead to death. The SynCardia Total Artificial Heart pumps up to 9.5 L/min of safe blood flow through each ventricle. This high volume of blood helps rejuvenate the patient. When a donor heart becomes available, most patients are in much better condition to receive their heart transplant.1st Case Report of Using Single-Site Cannulation ECMO
to Treat SynCardia Total Artificial Heart Patient
Published in Journal of Cardiothoracic Surgery

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that doctors at EJK Duisburg in Germany have published the first case report detailing use of single-site cannulation with extracorporeal membrane oxygenation (ECMO) to successfully treat adult respiratory distress syndrome in a patient implanted with the SynCardia temporary Total Artificial Heart. The case report was published in the August issue of the Journal of Cardiothoracic Surgery.

On Aug. 5, 2013, Frederic Thiollet surpassed two years of support with the SynCardia Total Artificial Heart. In the Shoulder Bag he’s holding is the Freedom® portable driver, which powers his Total Artificial Heart. The Backpack on the ground contains his back-up Freedom driver and extra batteries.French Man with SynCardia Total Artificial Heart
Surpasses Two Years of Support

Due to the global shortage of donor hearts, patients on the waiting list for a heart transplant can wait several months to several years for a match to be found. But for 36-year-old Frédéric Thiollet, who surpassed two years of support with the SynCardia temporary Total Artificial Heart on Aug. 5, he’s enjoying each and every day.

The SynCardia temporary Total Artificial Heart powered by the Freedom® portable driver is becoming the new standard of care for end-stage heart failure affecting both sides of the heart (biventricular failure).Over 50% of U.S. News & World Report’s “Best Heart Hospitals”
Are Certified to Implant the SynCardia Total Artificial Heart

SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that over half of the top 50 centers honored in U.S. News & World Report’s “Best Hospitals” list for cardiology and heart surgery for 2013-2014, offer the SynCardia temporary Total Artificial Heart.

Yusuf Enec is the first pediatric patient in Turkey to receive the SynCardia Total Artificial Heart. In the Backpack he is holding is the Freedom® portable driver, which powers his Total Artificial Heart.Turkey's 1st Pediatric Patient to Receive the
SynCardia Total Artificial Heart Celebrates 18th Birthday

Turning 18 years old is an important milestone in any young man's life, but even more so for Yusuf Enec. This time last year, Yusuf wasn't sure he'd live to see it. However, thanks to the SynCardia temporary Total Artificial Heart, today he has the chance to celebrate.

The Freedom® portable driver is the world's first wearable power supply for the SynCardia temporary Total Artificial Heart.100th SynCardia Total Artificial Heart Implanted in 2013

SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that as of July 18, a record-breaking 100 implants of the SynCardia temporary Total Artificial Heart have been performed by SynCardia Certified Centers in 2013. This milestone was achieved three months earlier than in 2012, when the 100th implant was performed on Oct. 16.

Stacie Sumandig walks her dog Kamodo wearing the Freedom® portable driver that powers her SynCardia Total Artificial Heart in the Backpack.Mother of Four with Congenital Heart Defect & Biventricular Heart Failure Bridged to Transplant with the SynCardia Total Artificial Heart

Stacie Sumandig is no stranger to heart problems. Born with a congenital heart defect called coarctation of the aorta, a narrowing of the major artery that carries blood away from the heart to the body, she had her first heart surgery at age 4, and an aortic valve replacement at age 31. But last October, when a virus attacked her aortic valve and destroyed her heart, the news she received at two different hospitals was grim: she probably wouldn’t make it through the weekend.

Nebraska’s first SynCardia Total Artificial Heart recipient, Greg Rathe, received a dual heart/kidney transplant at The Nebraska Medical Center on May 17, 2013.Nebraska Medical Center Transplants
State's 1st SynCardia Total Artificial Heart Patient

For the second time this year, Greg Rathe's medical history has made state history. The 42-year-old father of two, who became Nebraska's first patient to receive the SynCardia temporary Total Artificial Heart in March, recently became the state's fifth patient to receive a dual heart/kidney transplant...

The Companion 2 Driver, which can be docked in the Hospital Cart or Caddy, powers the SynCardia Total Artificial Heart from implant until the patient's condition stabilizes. Once stable, patients who are eligible can be switched to the smaller, wearable Freedom® portable driver.Companion 2 Hospital Driver for Powering Total Artificial Heart
Wins Silver at Medical Design Excellence Awards

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that its Companion 2 (C2) Driver System, which powers the SynCardia temporary Total Artificial Heart in the hospital, was selected as the Silver Winner in the Critical-Care and Emergency Medicine Products category of the Medical Design Excellence Awards (MDEA) held on June 19 in Philadelphia...

On May 21, 20-year-old Tiernee Gonzalez became the first SynCardia Total Artificial Heart patient to be discharged from Cincinnati Children’s to wait for a matching donor heart at home using the Freedom® portable driver.U.S. News & World Report Honors 7 SynCardia Certified Centers
Among "Best Children's Hospitals" for Cardiology and Heart Surgery

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that U.S. News & World Report has named seven SynCardia Certified Centers among the nation's "Best Children's Hospitals" for cardiology and heart surgery in its annual rankings for 2013-2014...

Justin Ryder Post-TransplantFormer Semi-Pro Arena Football Player Bridged to Heart Transplant
with the SynCardia Total Artificial Heart

When Justin Ryder, 35, was discharged from University of Arizona Medical Center in Tucson on May 20, he had a new donor heart beating in his chest and a new baby boy waiting for him at home in Las Vegas, his heart transplant made possible by 83 days of life with the SynCardia temporary Total Artificial Heart...

The SynCardia temporary Total Artificial Heart powered by the Freedom® portable driver in the Backpack is being featured as part of the $3 million Bodyworks Exhibition at the Glasgow Science Centre in Scotland.Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the Glasgow Science Centre in Scotland, which boasts more than 380,000 visitors annually, is featuring the SynCardia temporary Total Artificial Heart powered by the Freedom® portable driver as part of its $3 million Bodyworks Exhibition, one of the most advanced exhibitions of its kind...

Dr. Jack Copeland (center) is honored with the Pioneer in Transplantation Award at the annual meeting of the International Society of Heart & Lung Transplantation (ISHLT) on April 25 in Montreal. He is standing with Dr. David Taylor, ISHLT President 2012-2013 (left) and Dr. James Kirklin, ISHLT President 2009-2010.SynCardia Co-Founder Honored with Pioneer in Transplantation Award at ISHLT

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that world-renowned heart surgeon and SynCardia co-founder Jack G. Copeland, MD, was awarded the prestigious Pioneer in Transplantation Award at the annual meeting of the International Society of Heart & Lung Transplantation (ISHLT) on April 25 in Montreal...

May 7, 2013: Alfred Williams, the first patient in the Gulf South Region to receive the SynCardia Total Artificial Heart, with his mother Rebecca Williams at Ochsner Medical Center in New Orleans.Ochsner Medical Center Implants 1st SynCardia Total Artificial Heart in Gulf South Region*

When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old father of five had exhausted all treatment options for his enlarged heart. His condition, known as dilated cardiomyopathy, had progressed to end-stage heart failure affecting both sides of his heart. Unable to walk, he had been confined to a bed for months. Hospice care seemed like the only option Mr. Williams had left... until doctors approached him about becoming Ochsner's first patient to receive the SynCardia temporary Total Artificial Heart...

*Ochsner defines the Gulf South Region as the area extending from Louisiana to the Florida Panhandle

Chris Marshall hiked 607 miles while waiting for his donor heart using the Freedom portable driver to power his SynCardia Total Artificial Heart. Mr. Marshall, pictured with his dog Gracie, received his donor heart transplant on Sept. 12, 2012 and is doing well.SynCardia's Freedom® Portable Driver Selected as Silver Winner at Edison Awards

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that its Freedom® portable driver, the world's first wearable power supply for the SynCardia temporary Total Artificial Heart, was named the 2013 Silver Winner amongst Assistive Devices in the Science/Medical category of the Edison Awards on April 25 in Chicago...

In 2012, 125 implants of the Total Artificial Heart were performed by 54 SynCardia Certified Centers. In Q1 2013, 40 implants of the Total Artificial Heart were performed by 24 SynCardia Certified Centers.SynCardia Certified Centers Perform Record Number of Total Artificial Heart Implants During Q1 2013

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that a record 40 implants of the SynCardia temporary Total Artificial Heart were performed at 24 SynCardia Certified Centers during the quarter ended March 31, 2013...

March 27, 2013: The Nebraska Medical Center holds a news conference to announce the state's first implant of the SynCardia Total Artificial Heart. L to R: Ioana Dumitru, MD, John Um, MD, and Total Artificial Heart patient Greg Rathe. Nebraska Medical Center Implants State's First SynCardia Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Nebraska Medical Center in Omaha has performed the state's first implant of the SynCardia temporary Total Artificial Heart to save the life of 42-year-old Greg Rathe and bridge him to a second heart transplant...

The 50cc SynCardia Total Artificial Heart is designed for use in patients of smaller stature, including women and adolescents. It has been designated as a Humanitarian Use Device (HUD) by the FDA for destination therapy and pediatric bridge to transplant. Prior to clinical use, a Humanitarian Device Exemption (HDE) application for each indication must be approved by the FDA.20+ SynCardia Certified Centers to Present
Record Number of Total Artificial Heart Abstracts at ISHLT

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that more than 20 SynCardia Certified Centers representing four countries and more than 70 authors will present a record number of abstracts discussing the SynCardia temporary Total Artificial Heart at the annual meeting of the International Society for Heart & Lung Transplantation (ISHLT) being held April 24-27 in Montreal, Canada...

The Companion 2 Driver (left) is FDA-approved to power the SynCardia Total Artificial Heart in the hospital and on hospital grounds. It weighs 80% less than “Big Blue,” the original FDA-approved hospital driver.SynCardia's Companion 2 Driver Named a Finalist in the Medical Design Excellence Awards

SynCardia Systems, Inc., the privately-held manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that its Companion 2 (C2) Driver System, which powers the SynCardia temporary Total Artificial Heart in the hospital, has been selected as one of four finalists in the Critical-Care and Emergency Medicine Products category of the 15th Annual Medical Design Excellence Awards (MDEA). The winners will be announced on June 19 in Philadelphia...

February 2012: SynCardia Total Artificial Heart recipient Andrew Weaver, his wife Heather and their daughter Haley right before he was first diagnosed with heart problems. Intermountain Medical Center Uses SynCardia Total Artificial Heart
to Bridge 31-Year-Old Father to a Heart Transplant

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Andrew Weaver, a 31-year-old husband and father of one who arrived at Intermountain Medical Center in Salt Lake City in grave condition, has been successfully bridged to a heart transplant with the SynCardia temporary Total Artificial Heart and discharged home...

Marvin J. Slepian, MD, Professor of Medicine (Cardiology and Biomedical Engineering) at the University of Arizona, Co-founder, Chief Scientific Officer and Chairman of the Science Advisory Board for SynCardia Systems, Inc.Dr. Marvin Slepian Publishes Article in Journal of Biomechanics
on Downsizing the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart (TAH), announced today that Marvin J. Slepian, MD, the company's co-founder, chief scientific officer and chairman of the Science Advisory Board, has published a 10-page article in the Journal of Biomechanics (JBM) titled, "The SynCardia total artificial heart: in vivo, in vitro, and computational modeling studies"...

Feb. 4, 2013: SynCardia Total Artificial Heart recipient Bob Phillips, 74, leaves Penn State Hershey Medical Center with his wife Norma to wait for a matching donor heart at home. He is the oldest patient in the U.S. to be discharged from the hospital using the Freedom® portable driver to power his Total Artificial Heart. Photo by Darrell Peterson, Penn State Milton S. Hershey Medical Center74-Year-Old Becomes Oldest SynCardia Total Artificial Heart Patient
to Leave the Hospital Using the Freedom® Portable Driver

For 73 years, Bob Phillips was nothing but healthy. So healthy in fact, that he hadn't seen a doctor for 25 years. He never suspected that at age 74, he would become the oldest patient in the U.S. and the first in Pennsylvania to leave the hospital without a human heart...

The 70cc SynCardia temporary Total Artificial Heart (left) and the new, smaller 50cc SynCardia Total Artificial Heart, designed for patients of smaller stature, including women and adolescents. Together, the 70cc and 50cc Total Artificial Hearts will fit almost all adult men and women, and many adolescents, including patients with congenital conditions.SynCardia's 50cc Total Artificial Heart Receives Two HUD Designations
from the FDA for Destination Therapy and Pediatric Bridge to Transplant

SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration (FDA) has approved two Humanitarian Use Device (HUD) designations for the new 50cc Total Artificial Heart to be used for destination therapy and pediatric bridge to transplant. The 50cc device is a smaller version of the 70cc SynCardia temporary Total Artificial Heart, which received FDA approval as a bridge to transplant in 2004...

Dr. David L.S. Morales, chief of pediatric cardiothoracic surgery, plays foosball with his patient, 20-year-old Tiernee Gonzalez, the first SynCardia Total Artificial Heart recipient at Cincinnati Children’s Hospital Medical Center.SynCardia Total Artificial Heart Patient with End-Stage Renal Failure
Recovers Kidney Function after Two Months of Support

At only 20 years old, Tiernee Gonzalez has been battling two major diseases for most of her young life: heart failure and kidney failure. When she became the first patient at Cincinnati Children's Hospital Medical Center to receive the SynCardia temporary Total Artificial Heart on Nov. 9, her doctors hoped it would bring her one step closer to winning her battle against end-stage heart failure. What they didn't expect, was that it would also help save her one remaining kidney...

Chris Marshall hiked 607 miles with his wife Kathy using the Freedom portable driver to power his SynCardia Total Artificial Heart. Mr. Marshall received his donor heart transplant on Sept. 12, 2012 and is doing well.Forbes Ranks SynCardia Among "America's Most Promising Companies" for Second Straight Year

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, has been selected by Forbes as one of "America's Most Promising Companies" for the second consecutive year. On the list of 100 privately held, high-growth companies with bright futures, SynCardia was ranked #69, moving up eight spots from its #77 ranking last year...

Mr. Steven Tsui, Director of Heart and Lung Transplantation at Papworth Hospital, published an article on the SynCardia Total Artificial Heart in the December 2012 issue of the British Journal of Hospital Medicine.Article on the SynCardia Total Artificial Heart Published in British Journal of Hospital Medicine

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today the publication of an article in the December 2012 issue of the British Journal of Hospital Medicine titled "The total artificial heart in a cardiac replacement therapy programme"...

December 2012: SynCardia Total Artificial Heart patient Chad Washington enjoys a stroll with his 4-year-old son while wearing his Freedom portable driver in the Backpack, which powers his Total Artificial Heart. Mr. Washington was discharged from Ronald Reagan UCLA Medical Center on Dec. 10, 2012, and is currently waiting for a matching donor heart at home with his wife and son.SynCardia Sets New Records for Total Artificial Heart Implants, Revenue and Profit in 2012

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today record-setting results for 2012 for implants, revenue and profit...

L to R: Dr. Richard J. Shemin, SynCardia Total Artificial Heart patient Chad Washington and Dr. Murray Kwon at Ronald Reagan UCLA Medical Center. On Dec. 10, 2012, Washington was discharged from the hospital to wait for a matching donor heart at home using the Freedom® portable driver to power his Total Artificial Heart.Home for the Holidays: 1st SynCardia Total Artificial Heart Patient Discharged from UCLA

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Ronald Reagan UCLA Medical Center in Los Angeles has discharged its first patient to receive the SynCardia temporary Total Artificial Heart. Chad Washington, 35, left the hospital on Dec. 10, in time to celebrate the holidays at home with his wife and 4-year-old son using the Freedom® portable driver to power his Total Artificial Heart...

*The SynCardia temporary Total Artificial Heart was formerly known as the
SynCardia temporary CardioWest™ Total Artificial Heart.

FREE News Sign-Up

3538727_sBe Among the First to
Receive SynCardia News

... right in your email box